Table of Content
"1 INTRODUCTION 51
1.1 OBJECTIVES OF THE STUDY 51
1.2 MARKET DEFINITION 51
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 51
1.3 MARKET SCOPE 52
1.3.1 MARKETS COVERED 52
FIGURE 1 ANATOMIC PATHOLOGY MARKET SEGMENTATION 52
1.3.2 YEARS CONSIDERED FOR THE STUDY 53
1.4 CURRENCY 53
1.5 STAKEHOLDERS 53
1.6 SUMMARY OF CHANGES 54
2 RESEARCH METHODOLOGY 55
2.1 RESEARCH DATA 55
FIGURE 2 RESEARCH DESIGN 55
2.1.1 SECONDARY DATA 56
2.1.1.1 Secondary sources 57
2.1.2 PRIMARY DATA 57
2.1.2.1 Key data from primary sources 58
2.1.2.2 Key industry insights 59
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS (ANATOMIC PATHOLOGY MARKET) 59
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 60
2.2 MARKET SIZE ESTIMATION 60
2.2.1 APPROACH 1: REVENUE SHARE ANALYSIS (BOTTOM-UP APPROACH) 60
2.2.1.1 Bottom-up approach for the instruments and consumables market 61
FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 61
2.2.2 APPROACH 2: SECONDARY DATA & PRIMARY INTERVIEWS 61
2.2.3 APPROACH 3: TOP-DOWN APPROACH 61
FIGURE 6 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 62
2.2.3.1 Services market estimation based on the number of tests 62
2.2.3.2 Services market estimation based on procedures 63
FIGURE 7 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, OPPORTUNITIES, CHALLENGES, AND TRENDS IN THE ANATOMIC PATHOLOGY MARKET
(2021–2026) 64
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 64
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 65
FIGURE 9 DATA TRIANGULATION METHODOLOGY 65
2.4 MARKET SHARE ANALYSIS 66
2.5 ASSUMPTIONS FOR THE STUDY 66
2.6 RISK ASSESSMENT 67
TABLE 1 RISK ASSESSMENT: ANATOMIC PATHOLOGY MARKET 67
2.6.1 COVID-19 SPECIFIC ASSUMPTIONS 67
2.7 LIMITATIONS 68
2.7.1 METHODOLOGY-RELATED LIMITATIONS 68
2.7.2 SCOPE-RELATED LIMITATIONS 68
2.8 GROWTH RATE ASSUMPTIONS 68
2.9 COVID-19 ECONOMIC ASSESSMENT 68
2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 69
FIGURE 11 RECOVERY SCENARIO OF THE GLOBAL ECONOMY 70
3 EXECUTIVE SUMMARY 71
FIGURE 12 ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2021 VS. 2026 (USD MILLION) 71
FIGURE 13 ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 72
FIGURE 14 ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 72
FIGURE 15 ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION) 73
FIGURE 16 ANATOMIC PATHOLOGY MARKET, BY END USER,
2021 VS. 2026 (USD MILLION) 73
FIGURE 17 ANATOMIC PATHOLOGY MARKET: REGIONAL SNAPSHOT 74
4 PREMIUM INSIGHTS 75
4.1 ANATOMIC PATHOLOGY MARKET OVERVIEW 75
FIGURE 18 HIGH INCIDENCE OF CANCER TO DRIVE MARKET GROWTH 75
4.2 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE 76
FIGURE 19 SERVICES SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE
NORTH AMERICAN ANATOMIC PATHOLOGY MARKET 76
4.3 GEOGRAPHICAL SNAPSHOT OF THE ANATOMIC PATHOLOGY MARKET 77
FIGURE 20 COUNTRIES IN THE ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 77
5 MARKET OVERVIEW 78
5.1 INTRODUCTION 78
5.2 MARKET DYNAMICS 78
FIGURE 21 ANATOMIC PATHOLOGY MARKET: DRIVERS, OPPORTUNITIES, CHALLENGES, AND TRENDS 78
5.2.1 DRIVERS 79
5.2.1.1 High incidence of cancer and other target diseases 79
TABLE 2 INCREASING INCIDENCE OF CANCER, BY REGION,
2020 VS. 2030 VS. 2040 (MILLION) 79
TABLE 3 PROJECTED INCREASE IN THE GLOBAL NUMBER OF CANCER PATIENTS,
2015 VS. 2018 VS. 2035 79
5.2.1.2 Recommendations for cancer screening 80
5.2.1.3 Availability of reimbursement 80
5.2.1.4 Growing focus on personalized medicine 81
TABLE 4 % OF PERSONALIZED MEDICINES IN OVERALL DRUG APPROVAL BY FDA, 2014 TO 2020 81
5.2.2 OPPORTUNITIES 82
5.2.2.1 Increasing number of clinical trials pertaining to cancer drugs 82
5.2.2.2 Emerging markets offer lucrative opportunities 82
5.2.2.3 Companion diagnostics 83
5.2.3 CHALLENGES 83
5.2.3.1 Availability of refurbished products 83
5.2.3.2 Lack of skilled professionals 84
TABLE 5 NUMBER OF PATHOLOGISTS PER 100,000 POPULATION, BY COUNTRY, 2018 84
5.2.3.3 Product failures and recalls 84
5.2.3.4 Inadequate infrastructure and low awareness in middle- and low-income countries 84
5.2.4 TRENDS 85
5.2.4.1 Reagent rental agreements 85
5.2.5 IMPACT OF COVID-19 ON THE ANATOMIC PATHOLOGY MARKET 85
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 86
5.4 RANGES/SCENARIOS 87
5.4.1 ANATOMIC PATHOLOGY MARKET 87
FIGURE 22 PESSIMISTIC SCENARIO 87
FIGURE 23 OPTIMISTIC SCENARIO 87
FIGURE 24 REALISTIC SCENARIO 88
5.5 PRICING ANALYSIS 88
TABLE 6 PRICES OF ANATOMIC PATHOLOGY PRODUCTS 88
5.6 VALUE CHAIN ANALYSIS 89
FIGURE 25 MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASES 89
5.7 SUPPLY CHAIN ANALYSIS 90
FIGURE 26 DISTRIBUTION—A STRATEGY PREFERRED BY PROMINENT COMPANIES 90
5.8 ECOSYSTEM ANALYSIS 91
5.8.1 ROLE IN THE ECOSYSTEM 91
FIGURE 27 KEY PLAYERS IN THE ANATOMIC PATHOLOGY ECOSYSTEM 92
5.9 TECHNOLOGY ANALYSIS 92
TABLE 7 TECHNOLOGICAL ADVANCEMENT IN THE ANATOMIC PATHOLOGY MARKET (2018–2021) 92
5.10 REGULATORY LANDSCAPE 93
FIGURE 28 510(K) APPROVAL PROCESS 93
5.11 PATENT ANALYSIS 94
5.12 TRADE ANALYSIS 95
5.12.1 TRADE ANALYSIS FOR TISSUE PROCESSING SYSTEMS 95
TABLE 8 IMPORT DATA FOR TISSUE PROCESSING SYSTEMS, BY COUNTRY,
2016–2020 (USD MILLION) 95
TABLE 9 EXPORT DATA FOR TISSUE PROCESSING SYSTEMS, BY COUNTRY,
2016–2020 (USD MILLION) 95
5.13 PORTER’S FIVE FORCES ANALYSIS 95
TABLE 10 PORTER’S FIVE FORCES ANALYSIS (2020): ANATOMIC PATHOLOGY MARKET 96
5.13.1 THREAT OF NEW ENTRANTS 96
5.13.2 INTENSITY OF COMPETITIVE RIVALRY 96
5.13.3 BARGAINING POWER OF BUYERS 96
5.13.4 BARGAINING POWER OF SUPPLIERS 96
5.13.5 THREAT OF SUBSTITUTES 96
6 ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE 97
6.1 INTRODUCTION 98
TABLE 11 ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2020 (USD MILLION) 98
TABLE 12 ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2021–2026 (USD MILLION) 98
6.1.1 PRIMARY NOTES 98
6.1.1.1 Key industry insights 98
6.2 SERVICES 99
TABLE 13 ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 99
TABLE 14 ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 99
6.2.1 HISTOPATHOLOGY SERVICES 99
6.2.1.1 Rising incidence of cancer is a key factor driving market growth 99
FIGURE 29 STEPS IN HISTOPATHOLOGY SLIDE PREPARATION 99
TABLE 15 HISTOPATHOLOGY SERVICES MARKET, BY REGION,
2016–2020 (USD MILLION) 100
TABLE 16 HISTOPATHOLOGY SERVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 100
6.2.2 CYTOPATHOLOGY SERVICES 100
6.2.2.1 Government focus on cervical cancer screening has boosted the growth of the cytopathology services market 100
TABLE 17 CYTOPATHOLOGY SERVICES MARKET, BY REGION,
2016–2020 (USD MILLION) 101
TABLE 18 CYTOPATHOLOGY SERVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 101
6.3 CONSUMABLES 102
TABLE 19 ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2020 (USD MILLION) 102
TABLE 20 ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2021–2026 (USD MILLION) 102
6.3.1 ANTIBODIES 102
TABLE 21 ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION) 103
TABLE 22 ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION) 103
6.3.1.1 Primary antibodies 103
6.3.1.1.1 High specificity and accuracy of primary antibodies to drive the market 103
TABLE 23 PRIMARY ANTIBODIES MARKET, BY REGION, 2016–2020 (USD MILLION) 104
TABLE 24 PRIMARY ANTIBODIES MARKET, BY REGION, 2021–2026 (USD MILLION) 104
6.3.1.2 Secondary antibodies 104
6.3.1.2.1 Versatility of secondary antibodies ensuring their stable demand among end users 104
TABLE 25 SECONDARY ANTIBODIES MARKET, BY REGION, 2016–2020 (USD MILLION) 105
TABLE 26 SECONDARY ANTIBODIES MARKET, BY REGION, 2021–2026 (USD MILLION) 105
6.3.2 KITS & REAGENTS 105
TABLE 27 KITS & REAGENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 106
TABLE 28 KITS & REAGENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 106
6.3.2.1 Stains & solvents 106
6.3.2.1.1 Introduction of automation can limit the market growth 106
TABLE 29 STAINS & SOLVENTS MARKET, BY REGION, 2016–2020 (USD MILLION) 107
TABLE 30 STAINS & SOLVENTS MARKET, BY REGION, 2021–2026 (USD MILLION) 107
6.3.2.2 Fixatives 107
6.3.2.2.1 Adoption of non-toxic fixatives to drive market growth 107
TABLE 31 FIXATIVES MARKET, BY REGION, 2016–2020 (USD MILLION) 108
TABLE 32 FIXATIVES MARKET, BY REGION, 2021–2026 (USD MILLION) 108
6.3.2.3 Other kits & reagents 108
TABLE 33 OTHER KITS & REAGENTS MARKET, BY REGION, 2016–2020 (USD MILLION) 109
TABLE 34 OTHER KITS & REAGENTS MARKET, BY REGION, 2021–2026 (USD MILLION) 109
6.3.3 PROBES 109
6.3.3.1 Increasing research to aid the market growth 109
TABLE 35 PROBES MARKET, BY REGION, 2016–2020 (USD MILLION) 110
TABLE 36 PROBES MARKET, BY REGION, 2021–2026 (USD MILLION) 110
6.3.4 OTHER CONSUMABLES 110
TABLE 37 OTHER CONSUMABLES MARKET, BY REGION, 2016–2020 (USD MILLION) 111
TABLE 38 OTHER CONSUMABLES MARKET, BY REGION, 2021–2026 (USD MILLION) 111
6.4 INSTRUMENTS 111
TABLE 39 ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 112
TABLE 40 ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 112
6.4.1 SLIDE STAINING SYSTEMS 112
6.4.1.1 Availability of automated systems will drive market growth during the forecast period 112
TABLE 41 SLIDE STAINING SYSTEMS MARKET, BY REGION, 2016–2020 (USD MILLION) 113
TABLE 42 SLIDE STAINING SYSTEMS MARKET, BY REGION, 2021–2026 (USD MILLION) 113
6.4.2 TISSUE PROCESSING SYSTEMS 114
6.4.2.1 Rising adoption of automation is a key trend in the tissue processing systems market 114
TABLE 43 TISSUE PROCESSING SYSTEMS MARKET, BY REGION,
2016–2020 (USD MILLION) 114
TABLE 44 TISSUE PROCESSING SYSTEMS MARKET, BY REGION,
2021–2026 (USD MILLION) 114
6.4.3 CELL PROCESSORS 115
6.4.3.1 Cell processors are used to remove unwanted matter in samples—making them important instruments in the market 115
TABLE 45 CELL PROCESSORS MARKET, BY REGION, 2016–2020 (USD MILLION) 115
TABLE 46 CELL PROCESSORS MARKET, BY REGION, 2021–2026 (USD MILLION) 115
6.4.4 MICROTOMES 116
6.4.4.1 Rotary microtomes are the most commonly used microtomes 116
TABLE 47 MICROTOMES MARKET, BY REGION, 2016–2020 (USD MILLION) 116
TABLE 48 MICROTOMES MARKET, BY REGION, 2021–2026 (USD MILLION) 116
6.4.5 EMBEDDING SYSTEMS 117
6.4.5.1 Liquid paraffin is the most commonly used embedding medium 117
TABLE 49 EMBEDDING SYSTEMS MARKET, BY REGION, 2016–2020 (USD MILLION) 117
TABLE 50 EMBEDDING SYSTEMS MARKET, BY REGION, 2021–2026 (USD MILLION) 117
6.4.6 COVERSLIPPERS 118
6.4.6.1 Coverslippers are widely used instruments in research 118
TABLE 51 COVERSLIPPERS MARKET, BY REGION, 2016–2020 (USD MILLION) 118
TABLE 52 COVERSLIPPERS MARKET, BY REGION, 2021–2026 (USD MILLION) 118
6.4.7 OTHER INSTRUMENTS 119
TABLE 53 OTHER INSTRUMENTS MARKET, BY REGION, 2016–2020 (USD MILLION) 119
TABLE 54 OTHER INSTRUMENTS MARKET, BY REGION, 2021–2026 (USD MILLION) 119
7 ANATOMIC PATHOLOGY MARKET, BY APPLICATION 120
7.1 INTRODUCTION 121
7.1.1 PRIMARY NOTES 121
7.1.1.1 Key industry insights 121
TABLE 55 ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION) 121
TABLE 56 ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 121
7.2 DISEASE DIAGNOSTICS 122
TABLE 57 ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, BY DISEASE TYPE, 2016–2020 (USD MILLION) 122
TABLE 58 ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, BY DISEASE TYPE, 2021–2026 (USD MILLION) 122
7.2.1 CANCER 122
TABLE 59 ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2020 (USD MILLION) 123
TABLE 60 ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2021–2026 (USD MILLION) 123
7.2.1.1 Breast cancer 123
7.2.1.1.1 Breast cancer accounts for the highest mortality rate among cancers in North America 123
TABLE 61 BREAST CANCER INCIDENCE, BY REGION, 2020 VS. 2040 124
TABLE 62 ANATOMIC PATHOLOGY MARKET FOR BREAST CANCER, BY REGION,
2016–2020 (USD MILLION) 124
TABLE 63 ANATOMIC PATHOLOGY MARKET FOR BREAST CANCER, BY REGION,
2021–2026 (USD MILLION) 124
7.2.1.2 Gastrointestinal cancer 125
7.2.1.2.1 The rising incidence of gastric cancer will boost the market growth 125
TABLE 64 COLORECTAL CANCER INCIDENCE, BY REGION, 2020 VS. 2040 125
TABLE 65 ANATOMIC PATHOLOGY MARKET FOR GASTROINTESTINAL CANCER,
BY REGION, 2016–2020 (USD MILLION) 125
TABLE 66 ANATOMIC PATHOLOGY MARKET FOR GASTROINTESTINAL CANCER,
BY REGION, 2021–2026 (USD MILLION) 126
7.2.1.3 Lung cancer 126
7.2.1.3.1 Lung cancer is the most common cancer in the world 126
TABLE 67 LUNG CANCER INCIDENCE, BY REGION, 2020 VS. 2040 126
TABLE 68 ANATOMIC PATHOLOGY MARKET FOR LUNG CANCER, BY REGION,
2016–2020 (USD MILLION) 127
TABLE 69 ANATOMIC PATHOLOGY MARKET FOR LUNG CANCER, BY REGION,
2021–2026 (USD MILLION) 127
7.2.1.4 Prostate cancer 127
7.2.1.4.1 Prostate cancers are prevalent in the geriatric male population 127
TABLE 70 PROSTATE CANCER INCIDENCE, BY REGION, 2020 VS. 2040 128
TABLE 71 ANATOMIC PATHOLOGY MARKET FOR PROSTATE CANCER, BY REGION, 2016–2020 (USD MILLION) 128
TABLE 72 ANATOMIC PATHOLOGY MARKET FOR PROSTATE CANCER, BY REGION, 2021–2026 (USD MILLION) 128
7.2.1.5 Other cancers 129
TABLE 73 MELANOMA INCIDENCE, BY REGION, 2020 VS. 2040 129
TABLE 74 ANATOMIC PATHOLOGY MARKET FOR OTHER CANCERS, BY REGION,
2016–2020 (USD MILLION) 129
TABLE 75 ANATOMIC PATHOLOGY MARKET FOR OTHER CANCERS, BY REGION,
2021–2026 (USD MILLION) 130
7.2.2 OTHER DISEASES 130
TABLE 76 ANATOMIC PATHOLOGY MARKET FOR OTHER DISEASES, BY REGION,
2016–2020 (USD MILLION) 131
TABLE 77 ANATOMIC PATHOLOGY MARKET FOR OTHER DISEASES, BY REGION,
2021–2026 (USD MILLION) 131
7.3 MEDICAL RESEARCH 131
7.3.1 GROWING RESEARCH ACTIVITIES WILL DRIVE THE ADOPTION OF ANATOMIC PATHOLOGY PRODUCTS IN THIS APPLICATION SEGMENT 131
TABLE 78 ANATOMIC PATHOLOGY MARKET FOR MEDICAL RESEARCH, BY REGION, 2016–2020 (USD MILLION) 132
TABLE 79 ANATOMIC PATHOLOGY MARKET FOR MEDICAL RESEARCH, BY REGION, 2021–2026 (USD MILLION) 132
8 ANATOMIC PATHOLOGY MARKET, BY END USER 133
8.1 INTRODUCTION 134
8.1.1 PRIMARY NOTES 134
8.1.1.1 Key industry insights 134
TABLE 80 ANATOMIC PATHOLOGY MARKET, BY END USER, 2016–2020 (USD MILLION) 134
TABLE 81 ANATOMIC PATHOLOGY MARKET, BY END USER, 2021–2026 (USD MILLION) 134
8.2 HOSPITAL LABORATORIES 135
8.2.1 HOSPITAL LABORATORIES ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET 135
TABLE 82 ANATOMIC PATHOLOGY MARKET FOR HOSPITAL LABORATORIES, BY REGION, 2016–2020 (USD MILLION) 135
TABLE 83 ANATOMIC PATHOLOGY MARKET FOR HOSPITAL LABORATORIES, BY REGION, 2021–2026 (USD MILLION) 136
8.3 CLINICAL LABORATORIES 136
8.3.1 INCREASING OUTPATIENT SURGERIES TO DRIVE THE GROWTH OF THIS SEGMENT 136
TABLE 84 ANATOMIC PATHOLOGY MARKET FOR CLINICAL LABORATORIES, BY REGION, 2016–2020 (USD MILLION) 137
TABLE 85 ANATOMIC PATHOLOGY MARKET FOR CLINICAL LABORATORIES, BY REGION, 2021–2026 (USD MILLION) 137
8.4 OTHER END USERS 137
TABLE 86 ANATOMIC PATHOLOGY MARKET FOR OTHER END USERS, BY REGION,
2016–2020 (USD MILLION) 138
TABLE 87 ANATOMIC PATHOLOGY MARKET FOR OTHER END USERS, BY REGION,
2021–2026 (USD MILLION) 138
9 ANATOMIC PATHOLOGY MARKET, BY REGION 139
9.1 INTRODUCTION 140
TABLE 88 ANATOMIC PATHOLOGY MARKET, BY REGION, 2016–2020 (USD MILLION) 140
TABLE 89 ANATOMIC PATHOLOGY MARKET, BY REGION, 2021–2026 (USD MILLION) 140
9.2 NORTH AMERICA 141
FIGURE 30 NORTH AMERICA: CANCER INCIDENCE & MORTALITY, 2012–2035 141
FIGURE 31 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET SNAPSHOT 142
TABLE 90 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY COUNTRY,
2016–2020 (USD MILLION) 142
TABLE 91 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY COUNTRY,
2021–2026 (USD MILLION) 143
TABLE 92 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016–2020 (USD MILLION) 143
TABLE 93 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION) 143
TABLE 94 NORTH AMERICA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2016–2020 (USD MILLION) 144
TABLE 95 NORTH AMERICA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION) 144
TABLE 96 NORTH AMERICA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 144
TABLE 97 NORTH AMERICA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 145
TABLE 98 NORTH AMERICA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016–2020 (USD MILLION) 145
TABLE 99 NORTH AMERICA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION) 145
TABLE 100 NORTH AMERICA: ANTIBODIES MARKET, BY TYPE,
2016–2020 (USD MILLION) 146
TABLE 101 NORTH AMERICA: ANTIBODIES MARKET, BY TYPE,
2021–2026 (USD MILLION) 146
TABLE 102 NORTH AMERICA: KITS & REAGENTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 146
TABLE 103 NORTH AMERICA: KITS & REAGENTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 146
TABLE 104 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION) 147
TABLE 105 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 147
TABLE 106 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016–2020 (USD MILLION) 147
TABLE 107 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2021–2026 (USD MILLION) 147
TABLE 108 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016–2020 (USD MILLION) 148
TABLE 109 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2021–2026 (USD MILLION) 148
TABLE 110 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION) 148
TABLE 111 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION) 149
9.2.1 US 149
9.2.1.1 The US dominates the global anatomic pathology market 149
TABLE 112 US: CANCER INCIDENCE, BY TYPE OF CANCER, 2020 VS. 2040 150
TABLE 113 US: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2020 (USD MILLION) 150
TABLE 114 US: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2021–2026 (USD MILLION) 151
TABLE 115 US: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 151
TABLE 116 US: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 151
TABLE 117 US: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 152
TABLE 118 US: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 152
TABLE 119 US: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2020 (USD MILLION) 153
TABLE 120 US: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2021–2026 (USD MILLION) 153
TABLE 121 US: ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION) 153
TABLE 122 US: ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION) 154
TABLE 123 US: KITS & REAGENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 154
TABLE 124 US: KITS & REAGENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 154
TABLE 125 US: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION) 154
TABLE 126 US: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 155
TABLE 127 US: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2016–2020 (USD MILLION) 155
TABLE 128 US: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2021–2026 (USD MILLION) 155
TABLE 129 US: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2020 (USD MILLION) 156
TABLE 130 US: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2021–2026 (USD MILLION) 156
TABLE 131 US: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION) 156
TABLE 132 US: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION) 157
9.2.2 CANADA 157
9.2.2.1 High burden of cancer to support market growth 157
TABLE 133 CANADA: CANCER INCIDENCE, BY TYPE OF CANCER, 2020 VS. 2040 157
TABLE 134 CANADA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2020 (USD MILLION) 158
TABLE 135 CANADA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2021–2026 (USD MILLION) 158
TABLE 136 CANADA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 158
TABLE 137 CANADA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 159
TABLE 138 CANADA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 159
TABLE 139 CANADA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 159
TABLE 140 CANADA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2020 (USD MILLION) 160
TABLE 141 CANADA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2021–2026 (USD MILLION) 160
TABLE 142 CANADA: ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION) 160
TABLE 143 CANADA: ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION) 161
TABLE 144 CANADA: KITS & REAGENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 161
TABLE 145 CANADA: KITS & REAGENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 161
TABLE 146 CANADA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION) 161
TABLE 147 CANADA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 162
TABLE 148 CANADA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016–2020 (USD MILLION) 162
TABLE 149 CANADA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2021–2026 (USD MILLION) 162
TABLE 150 CANADA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2020 (USD MILLION) 163
TABLE 151 CANADA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2021–2026 (USD MILLION) 163
TABLE 152 CANADA: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION) 163
TABLE 153 CANADA: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION) 164
9.3 EUROPE 164
FIGURE 32 EUROPE: CANCER INCIDENCE & MORTALITY, 2012–2035 165
TABLE 154 EUROPE: ANATOMIC PATHOLOGY MARKET, BY COUNTRY,
2016–2020 (USD MILLION) 165
TABLE 155 EUROPE: ANATOMIC PATHOLOGY MARKET, BY COUNTRY,
2021–2026 (USD MILLION) 166
TABLE 156 EUROPE: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2020 (USD MILLION) 166
TABLE 157 EUROPE: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2021–2026 (USD MILLION) 166
TABLE 158 EUROPE: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 167
TABLE 159 EUROPE: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 167
TABLE 160 EUROPE: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 167
TABLE 161 EUROPE: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 168
TABLE 162 EUROPE: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2020 (USD MILLION) 168
TABLE 163 EUROPE: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2021–2026 (USD MILLION) 168
TABLE 164 EUROPE: ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION) 169
TABLE 165 EUROPE: ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION) 169
TABLE 166 EUROPE: KITS & REAGENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 169
TABLE 167 EUROPE: KITS & REAGENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 169
TABLE 168 EUROPE: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION) 170
TABLE 169 EUROPE: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 170
TABLE 170 EUROPE: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016–2020 (USD MILLION) 170
TABLE 171 EUROPE: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2021–2026 (USD MILLION) 170
TABLE 172 EUROPE: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2020 (USD MILLION) 171
TABLE 173 EUROPE: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2021–2026 (USD MILLION) 171
TABLE 174 EUROPE: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION) 171
TABLE 175 EUROPE: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION) 172
9.3.1 GERMANY 172
9.3.1.1 Availability of reimbursement for colorectal cancer screening to support market growth 172
TABLE 176 GERMANY: CANCER INCIDENCE, BY TYPE OF CANCER, 2020 VS. 2040 173
TABLE 177 GERMANY: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016–2020 (USD MILLION) 173
TABLE 178 GERMANY: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION) 173
TABLE 179 GERMANY: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 173
TABLE 180 GERMANY: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 174
TABLE 181 GERMANY: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 174
TABLE 182 GERMANY: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 174
TABLE 183 GERMANY: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016–2020 (USD MILLION) 175
TABLE 184 GERMANY: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION) 175
TABLE 185 GERMANY: ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION) 175
TABLE 186 GERMANY: ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION) 176
TABLE 187 GERMANY: KITS & REAGENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 176
TABLE 188 GERMANY: KITS & REAGENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 176
TABLE 189 GERMANY: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION) 176
TABLE 190 GERMANY: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 177
TABLE 191 GERMANY: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016–2020 (USD MILLION) 177
TABLE 192 GERMANY: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2021–2026 (USD MILLION) 177
TABLE 193 GERMANY: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2020 (USD MILLION) 178
TABLE 194 GERMANY: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2021–2026 (USD MILLION) 178
TABLE 195 GERMANY: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION) 178
TABLE 196 GERMANY: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION) 179
9.3.2 FRANCE 179
9.3.2.1 Government funding for cancer diagnosis & prevention to support market growth 179
TABLE 197 FRANCE: CANCER INCIDENCE, BY TYPE OF CANCER, 2020 VS. 2040 180
TABLE 198 FRANCE: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2020 (USD MILLION) 180
TABLE 199 FRANCE: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2021–2026 (USD MILLION) 180
TABLE 200 FRANCE: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 180
TABLE 201 FRANCE: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 181
TABLE 202 FRANCE: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 181
TABLE 203 FRANCE: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 181
TABLE 204 FRANCE: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2020 (USD MILLION) 182
TABLE 205 FRANCE: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2021–2026 (USD MILLION) 182
TABLE 206 FRANCE: ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION) 182
TABLE 207 FRANCE: ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION) 183
TABLE 208 FRANCE: KITS & REAGENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 183
TABLE 209 FRANCE: KITS & REAGENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 183
TABLE 210 FRANCE: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION) 183
TABLE 211 FRANCE: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 184
TABLE 212 FRANCE: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016–2020 (USD MILLION) 184
TABLE 213 FRANCE: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2021–2026 (USD MILLION) 184
TABLE 214 FRANCE: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2020 (USD MILLION) 185
TABLE 215 FRANCE: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2021–2026 (USD MILLION) 185
TABLE 216 FRANCE: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION) 185
TABLE 217 FRANCE: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION) 186
9.3.3 UK 186
9.3.3.1 Government initiatives to drive market growth in the UK 186
TABLE 218 UK: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2020 (USD MILLION) 187
TABLE 219 UK: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2021–2026 (USD MILLION) 187
TABLE 220 UK: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 187
TABLE 221 UK: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 187
TABLE 222 UK: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 188
TABLE 223 UK: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 188
TABLE 224 UK: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2020 (USD MILLION) 189
TABLE 225 UK: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2021–2026 (USD MILLION) 189
TABLE 226 UK: ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION) 189
TABLE 227 UK: ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION) 190
TABLE 228 UK: KITS & REAGENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 190
TABLE 229 UK: KITS & REAGENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 190
TABLE 230 UK: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION) 190
TABLE 231 UK: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 191
TABLE 232 UK: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2016–2020 (USD MILLION) 191
TABLE 233 UK: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2021–2026 (USD MILLION) 191
TABLE 234 UK: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2020 (USD MILLION) 192
TABLE 235 UK: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2021–2026 (USD MILLION) 192
TABLE 236 UK: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION) 192
TABLE 237 UK: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION) 193
9.3.4 ITALY 193
9.3.4.1 Growing geriatric population to support market growth in Italy 193
TABLE 238 ITALY: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025 194
TABLE 239 ITALY: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2020 (USD MILLION) 194
TABLE 240 ITALY: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2021–2026 (USD MILLION) 194
TABLE 241 ITALY: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 195
TABLE 242 ITALY: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 195
TABLE 243 ITALY: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 195
TABLE 244 ITALY: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 196
TABLE 245 ITALY: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2020 (USD MILLION) 196
TABLE 246 ITALY: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2021–2026 (USD MILLION) 196
TABLE 247 ITALY: ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION) 197
TABLE 248 ITALY: ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION) 197
TABLE 249 ITALY: KITS & REAGENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 197
TABLE 250 ITALY: KITS & REAGENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 197
TABLE 251 ITALY: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION) 198
TABLE 252 ITALY: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 198
TABLE 253 ITALY: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2016–2020 (USD MILLION) 198
TABLE 254 ITALY: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2021–2026 (USD MILLION) 198
TABLE 255 ITALY: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2020 (USD MILLION) 199
TABLE 256 ITALY: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2021–2026 (USD MILLION) 199
TABLE 257 ITALY: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION) 199
TABLE 258 ITALY: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION) 200"
"9.3.5 SPAIN 200
9.3.5.1 High incidence of chronic diseases to drive the Spanish market 200
TABLE 259 SPAIN: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025 200
TABLE 260 SPAIN: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2020 (USD MILLION) 201
TABLE 261 SPAIN: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2021–2026 (USD MILLION) 201
TABLE 262 SPAIN: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 201
TABLE 263 SPAIN: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 202
TABLE 264 SPAIN: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 202
TABLE 265 SPAIN: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 202
TABLE 266 SPAIN: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2020 (USD MILLION) 203
TABLE 267 SPAIN: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2021–2026 (USD MILLION) 203
TABLE 268 SPAIN: ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION) 203
TABLE 269 SPAIN: ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION) 204
TABLE 270 SPAIN: KITS & REAGENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 204
TABLE 271 SPAIN: KITS & REAGENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 204
TABLE 272 SPAIN: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION) 204
TABLE 273 SPAIN: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 205
TABLE 274 SPAIN: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2016–2020 (USD MILLION) 205
TABLE 275 SPAIN: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2021–2026 (USD MILLION) 205
TABLE 276 SPAIN: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2020 (USD MILLION) 206
TABLE 277 SPAIN: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2021–2026 (USD MILLION) 206
TABLE 278 SPAIN: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION) 206
TABLE 279 SPAIN: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION) 207
9.3.6 REST OF EUROPE 207
TABLE 280 ROE: CANCER INCIDENCE, BY COUNTRY, 2020 VS. 2040 207
TABLE 281 ROE: LUNG CANCER INCIDENCE, BY COUNTRY, 2020 VS. 2040 207
TABLE 282 ROE: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2020 (USD MILLION) 208
TABLE 283 ROE: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2021–2026 (USD MILLION) 208
TABLE 284 ROE: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 209
TABLE 285 ROE: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 209
TABLE 286 ROE: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 209
TABLE 287 ROE: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 210
TABLE 288 ROE: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2020 (USD MILLION) 210
TABLE 289 ROE: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2021–2026 (USD MILLION) 210
TABLE 290 ROE: ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION) 211
TABLE 291 ROE: ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION) 211
TABLE 292 ROE: KITS & REAGENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 211
TABLE 293 ROE: KITS & REAGENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 211
TABLE 294 ROE: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION) 212
TABLE 295 ROE: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 212
TABLE 296 ROE: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2016–2020 (USD MILLION) 212
TABLE 297 ROE: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2021–2026 (USD MILLION) 212
TABLE 298 ROE: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2020 (USD MILLION) 213
TABLE 299 ROE: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2021–2026 (USD MILLION) 213
TABLE 300 ROE: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION) 213
TABLE 301 ROE: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION) 214
9.4 ASIA PACIFIC 214
FIGURE 33 ASIA PACIFIC: CANCER INCIDENCE & MORTALITY, 2012–2035 215
FIGURE 34 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET SNAPSHOT 216
TABLE 302 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY COUNTRY,
2016–2020 (USD MILLION) 216
TABLE 303 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY COUNTRY,
2021–2026 (USD MILLION) 217
TABLE 304 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016–2020 (USD MILLION) 217
TABLE 305 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION) 217
TABLE 306 ASIA PACIFIC: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 218
TABLE 307 ASIA PACIFIC: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 218
TABLE 308 ASIA PACIFIC: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 218
TABLE 309 ASIA PACIFIC: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 219
TABLE 310 ASIA PACIFIC: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016–2020 (USD MILLION) 219
TABLE 311 ASIA PACIFIC: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION) 219
TABLE 312 ASIA PACIFIC: ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION) 220
TABLE 313 ASIA PACIFIC: ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION) 220
TABLE 314 ASIA PACIFIC: KITS & REAGENTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 220
TABLE 315 ASIA PACIFIC: KITS & REAGENTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 220
TABLE 316 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION) 221
TABLE 317 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 221
TABLE 318 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016–2020 (USD MILLION) 221
TABLE 319 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2021–2026 (USD MILLION) 221
TABLE 320 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016–2020 (USD MILLION) 222
TABLE 321 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2021–2026 (USD MILLION) 222
TABLE 322 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION) 222
TABLE 323 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION) 223
9.4.1 JAPAN 223
9.4.1.1 Presence of a well-developed healthcare system to support market growth in Japan 223
TABLE 324 JAPAN: CANCER INCIDENCE, BY TYPE OF CANCER, 2020 VS. 2040 224
TABLE 325 JAPAN: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2020 (USD MILLION) 224
TABLE 326 JAPAN: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2021–2026 (USD MILLION) 224
TABLE 327 JAPAN: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 224
TABLE 328 JAPAN: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 225
TABLE 329 JAPAN: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 225
TABLE 330 JAPAN: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 225
TABLE 331 JAPAN: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2020 (USD MILLION) 226
TABLE 332 JAPAN: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2021–2026 (USD MILLION) 226
TABLE 333 JAPAN: ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION) 226
TABLE 334 JAPAN: ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION) 227
TABLE 335 JAPAN: KITS & REAGENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 227
TABLE 336 JAPAN: KITS & REAGENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 227
TABLE 337 JAPAN: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION) 227
TABLE 338 JAPAN: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 228
TABLE 339 JAPAN: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2016–2020 (USD MILLION) 228
TABLE 340 JAPAN: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2021–2026 (USD MILLION) 228
TABLE 341 JAPAN: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2020 (USD MILLION) 229
TABLE 342 JAPAN: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2021–2026 (USD MILLION) 229
TABLE 343 JAPAN: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION) 229
TABLE 344 JAPAN: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION) 230
9.4.2 CHINA 230
9.4.2.1 High investments in R&D to drive the market growth 230
TABLE 345 CHINA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025 230
TABLE 346 CHINA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2020 (USD MILLION) 231
TABLE 347 CHINA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2021–2026 (USD MILLION) 231
TABLE 348 CHINA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 231
TABLE 349 CHINA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 231
TABLE 350 CHINA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 232
TABLE 351 CHINA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 232
TABLE 352 CHINA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2020 (USD MILLION) 233
TABLE 353 CHINA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2021–2026 (USD MILLION) 233
TABLE 354 CHINA: ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION) 233
TABLE 355 CHINA: ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION) 234
TABLE 356 CHINA: KITS & REAGENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 234
TABLE 357 CHINA: KITS & REAGENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 234
TABLE 358 CHINA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION) 234
TABLE 359 CHINA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 235
TABLE 360 CHINA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2016–2020 (USD MILLION) 235
TABLE 361 CHINA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2021–2026 (USD MILLION) 235
TABLE 362 CHINA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2020 (USD MILLION) 236
TABLE 363 CHINA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2021–2026 (USD MILLION) 236
TABLE 364 CHINA: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION) 236
TABLE 365 CHINA: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION) 237
9.4.3 INDIA 237
9.4.3.1 Expanding healthcare sector in the country to drive market growth 237
TABLE 366 INDIA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025 237
TABLE 367 INDIA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2020 (USD MILLION) 238
TABLE 368 INDIA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2021–2026 (USD MILLION) 238
TABLE 369 INDIA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 238
TABLE 370 INDIA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 239
TABLE 371 INDIA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 239
TABLE 372 INDIA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 239
TABLE 373 INDIA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2020 (USD MILLION) 240
TABLE 374 INDIA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2021–2026 (USD MILLION) 240
TABLE 375 INDIA: ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION) 240
TABLE 376 INDIA: ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION) 241
TABLE 377 INDIA: KITS & REAGENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 241
TABLE 378 INDIA: KITS & REAGENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 241
TABLE 379 INDIA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION) 241
TABLE 380 INDIA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 242
TABLE 381 INDIA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2016–2020 (USD MILLION) 242
TABLE 382 INDIA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2021–2026 (USD MILLION) 242
TABLE 383 INDIA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2020 (USD MILLION) 243
TABLE 384 INDIA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2021–2026 (USD MILLION) 243
TABLE 385 INDIA: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION) 243
TABLE 386 INDIA: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION) 244
9.4.4 REST OF ASIA PACIFIC 244
TABLE 387 ROAPAC: INCIDENCE OF CANCER, BY COUNTRY, 2020 VS. 2040 245
TABLE 388 ROAPAC: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2020 (USD MILLION) 245
TABLE 389 ROAPAC: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2021–2026 (USD MILLION) 245
TABLE 390 ROAPAC: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 246
TABLE 391 ROAPAC: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 246
TABLE 392 ROAPAC: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 246
TABLE 393 ROAPAC: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 247
TABLE 394 ROAPAC: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2020 (USD MILLION) 247
TABLE 395 ROAPAC: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2021–2026 (USD MILLION) 247
TABLE 396 ROAPAC: ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION) 248
TABLE 397 ROAPAC: ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION) 248
TABLE 398 ROAPAC: KITS & REAGENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 248
TABLE 399 ROAPAC: KITS & REAGENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 248
TABLE 400 ROAPAC: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION) 249
TABLE 401 ROAPAC: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 249
TABLE 402 ROAPAC: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016–2020 (USD MILLION) 249
TABLE 403 ROAPAC: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2021–2026 (USD MILLION) 249
TABLE 404 ROAPAC: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2020 (USD MILLION) 250
TABLE 405 ROAPAC: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2021–2026 (USD MILLION) 250
TABLE 406 ROAPAC: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION) 250
TABLE 407 ROAPAC: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION) 251
9.5 REST OF THE WORLD 251
TABLE 408 ROW: ANATOMIC PATHOLOGY MARKET, BY REGION,
2016–2020 (USD MILLION) 251
TABLE 409 ROW: ANATOMIC PATHOLOGY MARKET, BY REGION,
2021–2026 (USD MILLION) 252
TABLE 410 ROW: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2020 (USD MILLION) 252
TABLE 411 ROW: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2021–2026 (USD MILLION) 252
TABLE 412 ROW: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 252
TABLE 413 ROW: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 253
TABLE 414 ROW: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 253
TABLE 415 ROW: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 253
TABLE 416 ROW: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2020 (USD MILLION) 254
TABLE 417 ROW: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2021–2026 (USD MILLION) 254
TABLE 418 ROW: ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION) 254
TABLE 419 ROW: ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION) 255
TABLE 420 ROW: KITS & REAGENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 255
TABLE 421 ROW: KITS & REAGENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 255
TABLE 422 ROW: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION) 255
TABLE 423 ROW: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 256
TABLE 424 ROW: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2016–2020 (USD MILLION) 256
TABLE 425 ROW: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2021–2026 (USD MILLION) 256
TABLE 426 ROW: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2020 (USD MILLION) 257
TABLE 427 ROW: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2021–2026 (USD MILLION) 257
TABLE 428 ROW: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION) 257
TABLE 429 ROW: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION) 258
9.5.1 LATIN AMERICA 258
9.5.1.1 Cancer screening programs to support market growth 258
TABLE 430 LUNG CANCER INCIDENCE IN KEY LATIN AMERICAN COUNTRIES,
2018 VS. 2025 258
TABLE 431 LIVER CANCER INCIDENCE IN KEY LATIN AMERICAN COUNTRIES,
2018 VS. 2025 259
TABLE 432 BREAST CANCER INCIDENCE IN KEY LATIN AMERICAN COUNTRIES,
2018 VS. 2025 259
TABLE 433 LATIN AMERICA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016–2020 (USD MILLION) 260
TABLE 434 LATIN AMERICA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION) 260
TABLE 435 LATIN AMERICA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 260
TABLE 436 LATIN AMERICA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 261
TABLE 437 LATIN AMERICA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 261
TABLE 438 LATIN AMERICA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 261
TABLE 439 LATIN AMERICA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016–2020 (USD MILLION) 262
TABLE 440 LATIN AMERICA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION) 262
TABLE 441 LATIN AMERICA: ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION) 262
TABLE 442 LATIN AMERICA: ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION) 263
TABLE 443 LATIN AMERICA: KITS & REAGENTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 263
TABLE 444 LATIN AMERICA: KITS & REAGENTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 263
TABLE 445 LATIN AMERICA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION) 263
TABLE 446 LATIN AMERICA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 264
TABLE 447 LATIN AMERICA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016–2020 (USD MILLION) 264
TABLE 448 LATIN AMERICA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2021–2026 (USD MILLION) 264
TABLE 449 LATIN AMERICA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016–2020 (USD MILLION) 265
TABLE 450 LATIN AMERICA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2021–2026 (USD MILLION) 265
TABLE 451 LATIN AMERICA: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION) 265
TABLE 452 LATIN AMERICA: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION) 266
9.5.2 MIDDLE EAST & AFRICA 266
9.5.2.1 Increasing incidence of cancer in Africa to support market growth 266
TABLE 453 AFRICA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025 266
TABLE 454 MEA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2020 (USD MILLION) 267
TABLE 455 MEA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2021–2026 (USD MILLION) 267
TABLE 456 MEA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 268
TABLE 457 MEA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 268
TABLE 458 MEA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 268
TABLE 459 MEA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 269
TABLE 460 MEA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2020 (USD MILLION) 269
TABLE 461 MEA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2021–2026 (USD MILLION) 269
TABLE 462 MEA: ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION) 270
TABLE 463 MEA: ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION) 270
TABLE 464 MEA: KITS & REAGENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 270
TABLE 465 MEA: KITS & REAGENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 270
TABLE 466 MEA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION) 271
TABLE 467 MEA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 271
TABLE 468 MEA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2016–2020 (USD MILLION) 271
TABLE 469 MEA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2021–2026 (USD MILLION) 271
TABLE 470 MEA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2020 (USD MILLION) 272
TABLE 471 MEA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2021–2026 (USD MILLION) 272
TABLE 472 MEA: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION) 272
TABLE 473 MEA: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION) 273
10 COMPETITIVE LANDSCAPE 274
10.1 OVERVIEW 274
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 274
TABLE 474 OVERVIEW OF STRATEGIES ADOPTED BY KEY MARKET PLAYERS 274
10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS (INSTRUMENTS AND CONSUMABLES) 275
FIGURE 35 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE ANATOMIC PATHOLOGY MARKET (INSTRUMENTS AND CONSUMABLES) 276
10.4 MARKET SHARE ANALYSIS (INSTRUMENTS AND CONSUMABLES) 276
FIGURE 36 ANATOMIC PATHOLOGY MARKET SHARE ANALYSIS, 2020 (INSTRUMENTS AND CONSUMABLES) 276
TABLE 475 ANATOMIC PATHOLOGY MARKET (INSTRUMENTS AND CONSUMABLES): DEGREE OF COMPETITION (2020) 277
10.5 COMPANY EVALUATION QUADRANT 278
10.5.1 STARS 278
10.5.2 EMERGING LEADERS 278
10.5.3 PERVASIVE PLAYERS 278
10.5.4 PARTICIPANTS 278
FIGURE 37 ANATOMIC PATHOLOGY MARKET: COMPANY EVALUATION QUADRANT, 2020 279
10.6 COMPANY EVALUATION QUADRANT: SMES/START-UPS 279
10.6.1 PROGRESSIVE COMPANIES 279
10.6.2 STARTING BLOCKS 279
10.6.3 RESPONSIVE COMPANIES 280
10.6.4 DYNAMIC COMPANIES 280
FIGURE 38 ANATOMIC PATHOLOGY MARKET: COMPANY EVALUATION QUADRANT FOR SMES & START-UPS, 2020 280
10.7 COMPETITIVE SCENARIO 281
10.7.1 PRODUCT LAUNCHES 281
TABLE 476 KEY PRODUCT LAUNCHES 281
10.7.2 DEALS 282
TABLE 477 KEY DEALS 282
10.7.3 OTHER DEVELOPMENTS 283
TABLE 478 OTHER KEY DEVELOPMENTS 283
10.8 COMPETITIVE BENCHMARKING 284
10.8.1 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS 284
TABLE 479 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS IN THE ANATOMIC PATHOLOGY MARKET FOR INSTRUMENTS AND CONSUMABLES 284
TABLE 480 PRODUCT FOOTPRINT OF COMPANIES 285
TABLE 481 REGIONAL FOOTPRINT OF COMPANIES 286
11 COMPANY PROFILES 287
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1 KEY PLAYERS 287
11.1.1 F. HOFFMAN-LA ROCHE LTD. 287
TABLE 482 F. HOFFMAN-LA ROCHE LTD.: BUSINESS OVERVIEW 287
FIGURE 39 COMPANY SNAPSHOT: F. HOFFMAN-LA ROCHE LTD. (2020) 288
11.1.2 DANAHER CORPORATION 291
TABLE 483 DANAHER CORPORATION: BUSINESS OVERVIEW 291
FIGURE 40 COMPANY SNAPSHOT: DANAHER (2020) 292
11.1.3 PHC HOLDINGS CORPORATION 295
TABLE 484 PHC HOLDINGS CORPORATION: BUSINESS OVERVIEW 295
11.1.4 ABCAM PLC. 297
TABLE 485 ABCAM PLC.: BUSINESS OVERVIEW 297
FIGURE 41 COMPANY SNAPSHOT: ABCAM PLC. (2020) 298
11.1.5 HOLOGIC, INC. 301
TABLE 486 HOLOGIC, INC.: BUSINESS OVERVIEW 301
FIGURE 42 COMPANY SNAPSHOT: HOLOGIC, INC. (2020) 302
11.1.6 AGILENT TECHNOLOGIES 304
TABLE 487 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW 304
FIGURE 43 COMPANY SNAPSHOT: AGILENT TECHNOLOGIES (2020) 305
11.1.7 BECTON, DICKINSON AND COMPANY 307
TABLE 488 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 307
FIGURE 44 COMPANY SNAPSHOT: BECTON, DICKINSON AND COMPANY (2020) 308
11.1.8 SAKURA FINETEK USA INC. 310
TABLE 489 SAKURA FINETEK: BUSINESS OVERVIEW 310
11.1.9 MERCK KGAA 314
TABLE 490 MERCK KGAA: BUSINESS OVERVIEW 314
FIGURE 45 COMPANY SNAPSHOT: MERCK KGAA (2020) 315
11.1.10 BIO SB 317
TABLE 491 BIO SB: BUSINESS OVERVIEW 317
11.2 OTHER PLAYERS 319
11.2.1 BIOGENEX 319
11.2.2 MILESTONE MEDICAL 320
11.2.3 HISTO-LINE LABORATORIES 321
11.2.4 DIAPATH S.P.A. 322
11.2.5 SLEE MEDICAL GMBH 323
11.2.6 AMOS SCIENTIFIC PTY LTD. 324
11.2.7 MEDITE MEDICAL GMBH 325
11.2.8 CELL SIGNALING TECHNOLOGY 326
11.2.9 CELLPATH LTD. 327
11.2.10 JINHUA YIDI MEDICAL APPLIANCE CO. LTD. 328
11.2.11 MICROS AUSTRIA 329
11.2.12 R. K. SCIENTIFIC INSTRUMENT PRIVATE LIMITED 330
11.2.13 LUPETEC 331
11.2.14 MEDIMEAS 332
11.2.15 BRIGHT INSTRUMENTS 333
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX 334
12.1 INSIGHTS FROM INDUSTRY EXPERTS 334
12.2 DISCUSSION GUIDE 334
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 339
12.4 AVAILABLE CUSTOMIZATIONS 341
12.5 RELATED REPORTS 342
12.6 AUTHOR DETAILS 343"
US $
Euro €
GBP £
